CRYO CELL INTERNATIONAL INC — Form SCHEDULE 13D/A
Filed July 7, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 72/100
What the filing says
CAMAC Fund, LP (managed by Eric Shahinian via Camac Capital, LLC) purchased 82,542 shares of Cryo-Cell International common stock between May 11 and July 6, 2026, at prices ranging from $3.115 to $3.450 per share. A single transaction on July 2, 2026 accounted for 47,046 shares at $3.299. This represents a material accumulation by an activist/significant shareholder filing under Schedule 13D.
Why this rating
82.5K shares worth ~$280M in nominal value, but at $3.255–$3.41 pricing totals ~$268K–$269K spent. Relative to $26.5M market cap, this represents ~1% of current market value and signals meaningful insider/activist accumulation. Significant for governance/control implications but not transformational in isolation.
See more from July 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.